alpha-thalassemia in the United Arab Emirates

Acta Haematol. 1998;100(1):49-53. doi: 10.1159/000040863.

Abstract

A neonatal screening survey of alpha-thalassemia (alpha-thal) among the United Arab Emirates (UAE) nationals was conducted on 418 consecutive cord blood samples. Our findings demonstrate that 49% of the cases studied were found with an alpha-globin gene defect. The gene frequency of the -alpha3.7 was 0.2847 and that of the -alpha4.2 was 0.0072. Four nondeletional alpha-thal mutations were found; alphaPA-1, alphaPA-2, Hb CS and alpha-5nt del with gene frequencies of 0.0036, 0.0012, 0.0024, and 0.0072, respectively. We also report here the genotype-phenotype correlation in 22 patients with Hb H disease or Hb H-like syndrome. Of these, 6 were homozygous for the alphaPA-1 mutation, 2 were homozygous for Hb CS, and 14 were compound heterozygous for either alphaPA-1, Hb CS, alpha-5nt del or --MED-I, with the -alpha3.7. The data reported here demonstrate that a considerable heterogeneity of alpha-thal mutations occurs in the UAE and that the incidence of alpha-thal in the indigenous population is one of the highest in the world. Our clinical data suggest that Hb H disease in the UAE has, in general, a mild to moderate phenotypic presentation.

MeSH terms

  • Gene Frequency
  • Globins / genetics*
  • Humans
  • Infant, Newborn
  • Mutation*
  • Neonatal Screening*
  • United Arab Emirates / epidemiology
  • alpha-Thalassemia / epidemiology*
  • alpha-Thalassemia / genetics*
  • alpha-Thalassemia / prevention & control

Substances

  • Globins